Commentary: Targeting the left atrial appendage
- PMID: 34647062
- PMCID: PMC8501241
- DOI: 10.1016/j.xjtc.2021.08.005
Commentary: Targeting the left atrial appendage
Figures
Comment on
- doi: 10.1016/j.xjtc.2021.07.009
References
-
- Ruff C.T., Giugliano R.P., Braunwald E., Hoffman E.B., Deenadayalu N., Ezekowitz M.D. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials. Lancet. 2014;383:955–962. - PubMed
-
- Whitlock R.P., Belley-Cote E.P., Healey J.S., Healey J.S., Brady K., Sharma M. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021;384:2081–2091. - PubMed
-
- Holmes D.R., Kar S., Price M.J., Whisenant B., Sievert H., Doshi S.K. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation vs. long term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12. - PubMed
Publication types
LinkOut - more resources
Full Text Sources